Gosh, I think we might have just recently, in the last hours from recording this episode, have some updates to the USA FDA regulations on peptides that are going to be in the future, so I think were going to see this more
Retatrutide in the Broader Research Landscape It's worth taking a moment to understand why such meticulous handling is warranted
Approval status: Unlike most peptides on this site, tesamorelin is FDA-approved (brand Egrifta / Egrifta SV ) but only for one specific indication: reducing excess abdominal fat in HIV-associated lipodystrophy
Table 2 summarizes some of the current FDA-approved CNS nasal products
ROS damage the mitochondria of dermal papilla cells, disrupt the ECM, accelerate collagen degradation, and impair the DNA repair mechanisms that keep follicular stem cells healthy and functionally active
Table 1 Summary table of the different methods to assess intestinal permeability